Liliana Ascione
0000-0002-2807-7400
5 papers found
Refreshing results…
Clinicopathological features and survival outcomes of luminal-like breast tumors with estrogen receptor loss at metastatic recurrence: A case-control study
A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing data
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience
PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards
Missing publications? Search for publications with a matching author name.